IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Washington University School of Medicine
St. Jude Children's Research Hospital
Emory University
University of Utah
University of Virginia
Imperial College London
Memorial Sloan Kettering Cancer Center
Albert Einstein College of Medicine
Albert Einstein College of Medicine
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Alliance for Clinical Trials in Oncology
Mayo Clinic
University of Wisconsin, Madison
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
University of Utah
Washington University School of Medicine
Duke University